Inventor
DOHERTY GEORGE A
US38 patents
⚠️ This page may combine multiple inventors who share the name “DOHERTY GEORGE A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
13 patentsUS9174982B2Nov 3, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC38 citations98
US9029404B2May 12, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC19 citations92
US8952157B2Feb 10, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC22 citations91
US9303025B2Apr 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC11 citations84
US9125913B2Sep 8, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC10 citations84
US9072748B2Jul 7, 2015
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9073855B2Jul 7, 2015
BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9045420B2Jun 2, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9034875B2May 19, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC19 citations84
US10676485B2Jun 9, 2020
Macrocyclic MCL-1 inhibitors and methods of use
ABBVIE INC2 citations73
US11897864B2Feb 13, 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US11964990B2Apr 23, 2024
1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors
ABBVIE INC1 citations59
US11633497B2Apr 25, 2023
Anti-c-Met antibody drug conjugates
ABBVIE INC1 citations59
DOHERTY GEORGE A
7 patentsUS8580794B2Nov 12, 2013
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
DOHERTY GEORGE A44 citations93
US8557983B2Oct 15, 2013
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
DOHERTY GEORGE A44 citations93
US8304407B2Nov 6, 2012
8-substituted benzoazepines as toll-like receptor modulators
DOHERTY GEORGE A5 citations61
US8163738B2Apr 24, 2012
Aminodiazepines as toll-like receptor modulators
DOHERTY GEORGE A3 citations61
US8153622B2Apr 10, 2012
8-substituted benzoazepines as toll-like receptor modulators
DOHERTY GEORGE A4 citations60
US8492437B2Jul 23, 2013
4-substituted phenoxyphenylacetic acid derivatives
DOHERTY GEORGE A0 citations52
US8673898B2Mar 18, 2014
Aminodiazepines as toll-like receptor modulators
DOHERTY GEORGE A0 citations50
MERCK & CO INC
6 patentsUS7351725B2Apr 1, 2008
N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists
MERCK & CO INC40 citations93
US7309721B2Dec 18, 2007
Aminoalkylphosphonates and related compounds as Edg receptor agonists
MERCK & CO INC37 citations91
US7605171B2Oct 20, 2009
(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
MERCK & CO INC27 citations90
US7479504B2Jan 20, 2009
Edg receptor agonists
MERCK & CO INC28 citations90
US7220734B2May 22, 2007
1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists
MERCK & CO INC19 citations84
US6482840B2Nov 19, 2002
Substituted cyclic amidine derivatives as inhibitors of cell adhesion
MERCK & CO INC0 citations42
ARRAY BIOPHARMA INC
4 patentsUS9556139B2Jan 31, 2017
6-substituted phenoxychroman carboxylic acid derivatives
ARRAY BIOPHARMA INC1 citations62
US9096567B2Aug 4, 2015
6-substituted phenoxychroman carboxylic acid derivatives
ARRAY BIOPHARMA INC2 citations62
US8716498B2May 6, 2014
6-substituted phenoxychroman carboxylic acid derivatives
ARRAY BIOPHARMA INC2 citations62
US8362056B2Jan 29, 2013
4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
ARRAY BIOPHARMA INC0 citations42
BRUNCKO MILAN
3 patentsUS8586754B2Nov 19, 2013
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN59 citations97
US8563735B2Oct 22, 2013
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN72 citations97
US8546399B2Oct 1, 2013
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
BRUNCKO MILAN100 citations97